AJP - Renal AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 272: F597-F601, 1997;
0363-6127/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, D.
Right arrow Articles by Blantz, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, D.
Right arrow Articles by Blantz, R. C.

AJP - Renal Physiology, Vol 272, Issue 5 597-F601, Copyright © 1997 by American Physiological Society


ARTICLES

Agmatine affects glomerular filtration via a nitric oxide synthase-dependent mechanism

D. Schwartz, O. W. Peterson, M. Mendonca, J. Satriano, M. Lortie and R. C. Blantz
Division of Nephrology-Hypertension, University of California, School of Medicine, La Jolla 92093, USA.

Arginine decarboxylase is present in the kidney and metabolizes the amino acid, arginine, to agmatine. Agmatine increases filtration rate in single nephrons (J. J. Lortie, W. F. Novotny, O. W. Peterson, V. Vallon, K. Malvey, M. Mendonca, J. Satriano, P. Insel, S. C. Thomson, and R. C. Blantz. J. Clin. Invest. 97:413-420, 1996). Experiments were conducted to determine whether exogenously administered agmatine exerts these effects via interaction with nitric oxide synthase (NOS) and whether this interaction depends upon alpha 2-adrenergic receptors. Agmatine microperfused (1 microM) into the urinary space of surface glomeruli of the rat increased nephron filtration rate from 33 +/- 4 to 40 +/- 5 nl/min with complete recovery within 10 min. When NG-monomethyl-L-arginine (L-NMMA), a nonselective NOS inhibitor, was systemically infused, agmatine no longer increased single-nephron glomerular filtration rate (SNGFR). BHT-933, an alpha 2-adrenergic agonist, did not increase SNGFR and was unaffected by concurrent L-NMMA. In vitro incubation of freshly harvested glomeruli with agmatine resulted in significant increases in the generation of cGMP, effects similar to carbachol, and blocked by nitro-L-arginine methyl ester (L-NAME) but not yohimbine, an alpha 2-adrenergic antagonist. Agmatine exerts effects on glomerular ultrafiltration via a constitutive NOS-dependent mechanism, and this does not require the participation of alpha 2-adrenoreceptors.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Satriano, R. Cunard, O. W. Peterson, T. Dousa, F. B. Gabbai, and R. C. Blantz
Effects on kidney filtration rate by agmatine requires activation of ryanodine channels for nitric oxide generation
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F795 - F800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Baylis
Nitric oxide deficiency in chronic kidney disease
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F1 - F9.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Sabbatini, A. Pisani, F. Uccello, G. Fuiano, R. Alfieri, A. Cesaro, B. Cianciaruso, and V. E. Andreucci
Arginase inhibition slows the progression of renal failure in rats with renal ablation
Am J Physiol Renal Physiol, April 1, 2003; 284(4): F680 - F687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. K. Mistry, T. J. Burwell, R. M. Chambers, L. Rudolph-Owen, F. Spaltmann, W. J. Cook, and S. M. Morris Jr
Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus
Am J Physiol Gastrointest Liver Physiol, February 1, 2002; 282(2): G375 - G381.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Babál, M. Ruchko, C. C. Campbell, S. P. Gilmour, J. L. Mitchell, J. W. Olson, and M. N. Gillespie
Regulation of Ornithine Decarboxylase Activity and Polyamine Transport by Agmatine in Rat Pulmonary Artery Endothelial Cells
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 372 - 377.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
I. H. C. VOS, T. J. RABELINK, B. DORLAND, R. LOOS, B. V. MIDDELAAR, H.-J. GRÖNE, and J. A. JOLES
L-Arginine Supplementation Improves Function and Reduces Inflammation in Renal Allografts
J. Am. Soc. Nephrol., February 1, 2001; 12(2): 361 - 367.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
S. ISHIZUKA, R. CUNARD, S. POUCELL-HATTON, L. WEAD, M. LORTIE, S. C. THOMSON, F. B. GABBAI, J. SATRIANO, and R. C. BLANTZ
Agmatine Inhibits Cell Proliferation and Improves Renal Function in Anti--Thy-1 Glomerulonephritis
J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2256 - 2264.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. J. Lortie, S. Ishizuka, D. Schwartz, and R. C. Blantz
Bioactive products of arginine in sepsis: tissue and plasma composition after LPS and iNOS blockade
Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1191 - C1199.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online